{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:49:48Z","timestamp":1791575388223,"version":"4.3.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Community pharmacists are most accessible to patients. Hence, they have a crucial role in ensuring drug safety by detecting and reporting adverse drug reactions (ADRs). However, there may be gaps in their knowledge of ADR reporting systems and barriers they face in reporting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to assess community pharmacists\u2019 knowledge of ADR reporting systems in the Kingdom of Jordan, identify the barriers they face in reporting ADRs, and explore the broader factors that influence their involvement in pharmacovigilance activities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In-depth, semi-structured, face-to-face interviews were held with 20 community pharmacists from different regions of Jordan to evaluate their understanding of ADR reporting, the obstacles they encountered, and the elements that could motivate them to report ADRs. The interviews were transcribed and subjected to thematic analysis to find recurrent themes and insights. The thematic analysis highlighted opportunities for continuing education and an absence of formal training as the main barriers to ADR reporting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Pharmacists reported dissatisfaction with time limits in their hectic work situations and the complexity of reporting procedures, especially the length and information demanded by ADR reporting forms. Another factor influencing low reporting rates was a perceived lack of acknowledgment and feedback. Participants proposed that encouraging ADR reporting with professional recognition or compensation and improving and digitizing the reporting process would promote increased participation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ADR reporting presents considerable difficulties for community pharmacists in Jordan, mostly because of administrative obstacles and an absence of official support and training. Enhancing pharmacovigilance efforts in Jordan could be achieved by providing incentives, simplifying the reporting procedure, and incorporating reporting into the current pharmacy management software.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1513611","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:59:05Z","timestamp":1736146745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Improving ADR reporting in Jordan: a qualitative exploration of pharmacists\u2019 perspectives"],"prefix":"10.3389","volume":"11","author":[{"given":"Amal K.","family":"Suleiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2165\/00002018-200528100-00003","article-title":"Clarification of terminology in drug safety","volume":"28","author":"Aronson","year":"2005","journal-title":"Drug Saf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jsps.2018.03.002","article-title":"Effect of educational intervention on healthcare providers' knowledge and perception towards pharmacovigilance: a tertiary teaching hospital experience","volume":"26","author":"Farha","year":"2018","journal-title":"Saudi Pharm J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12816\/0030523","article-title":"Medication errors in voluntary reported incidents at a Jordanian hospital","volume":"50","author":"Hammour","year":"2016","journal-title":"Jordan Med J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4197\/Med.28-2.6","article-title":"Adverse drug reactions reporting system: perceptions and awareness of community pharmacists in Jeddah, Saudi Arabia","author":"Almasri","year":"2021","journal-title":"J King Abdulaziz Univ Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2042098620938595","DOI":"10.1177\/2042098620938595","article-title":"Post-marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges, and the future","volume":"11","author":"Alomar","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.drudis.2008.12.012","article-title":"Decision support methods for the detection of adverse events in postmarketing data","volume":"14","author":"Hauben","year":"2009","journal-title":"Drug Discov Today"},{"key":"ref7","article-title":"Guideline on Good Pharmacovigilance Practices (GVP) Module VI\u2013Management and Reporting of Adverse Reactions to Medicinal Products (Rev 1). EMA\/873138\/2011 Rev 1. 2014","author":"Vi","year":"2014"},{"key":"ref8","first-page":"1","article-title":"The Role of Patient Satisfaction and Pharmacy Performance: The Current Scenario in Saudi Arabia","volume-title":"Pharmacy Practice","author":"Suleiman","year":"2024"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","article-title":"Epidemiology of adverse drug reactions in Europe: a review of recent observational studies","volume":"38","author":"Bouvy","year":"2015","journal-title":"Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11096-018-0700-2","article-title":"Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey","volume":"40","author":"Li","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00002018-200022020-00007","article-title":"Incidence and costs of adverse drug reactions during hospitalization: computerized monitoring versus stimulated spontaneous reporting","volume":"22","author":"Dormann","year":"2000","journal-title":"Drug Saf"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of hospital admission: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/pds.667","article-title":"Adverse drug reactions as a cause for admissions to a department of internal medicine","volume":"11","author":"Mj\u00f6rndal","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref14","article-title":"Safety of medicines: a guide to detecting and reporting adverse drug reactions; 2002","year":"2018"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1001\/jama.2022.9600","article-title":"Trends in adverse event rates in hospitalized patients, 2010-2019","volume":"328","author":"Eldridge","year":"2022","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14740338.2018.1491547","article-title":"The economic burden of preventable adverse drug reactions: a systematic review of observational studies","volume":"17","author":"Formica","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3126\/njdvl.v15i1.18051","article-title":"Patterns and outcomes of cutaneous adverse drug reactions in a hospital-based study","volume":"15","author":"Paudel","year":"2017","journal-title":"Nepal J Dermatol Venereol Leprol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.13005\/bpj\/1112","article-title":"Analysis of the national pharmacovigilance database in Jordan (2010-2014)","volume":"10","author":"Alsbou","year":"2017","journal-title":"Biomed Pharmacol J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","article-title":"Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature","volume":"14","author":"Onakpoya","year":"2016","journal-title":"BMC Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.59467\/jez.2024.27.2.2337","article-title":"A holistic approach to adverse drug reactions in hospitals: classification, risk factors, assessment and economic evaluation - a review","volume":"27","author":"Kumar","year":"2024","journal-title":"J Exp Zool India"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jsps.2021.08.014","article-title":"Patterns of adverse drug reactions (ADRs) in Saudi Arabia","volume":"30","author":"Yousef","year":"2022","journal-title":"Saudi Pharm J"},{"key":"ref22","first-page":"ckx186.064","article-title":"Adverse drug reactions \u2013 problems with spontaneous reporting systems: Festina Balidemaj","volume-title":"European Journal of Public Health","author":"Balidemaj","year":"2017"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1574884713666180308151805","article-title":"Knowledge, attitudes, and practices of pharmacovigilance and ADRs spontaneous reporting among pediatricians and pediatric residents in Jordan","volume":"13","author":"Mukattash","year":"2018","journal-title":"Curr Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14740338.2023.2223957","article-title":"Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015\u20132021)","volume":"22","author":"Mhaidat","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.18549\/PharmPract.2020.4.2184","article-title":"Primary health care policy and vision for community pharmacy and pharmacists in Jordan","volume":"18","author":"Basheti","year":"2020","journal-title":"Pharm Pract (Granada)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jsps.2023.05.016","article-title":"Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting","volume":"31","author":"El-Dahiyat","year":"2023","journal-title":"Saudi Pharm J"},{"key":"ref28","volume-title":"Transforming qualitative information: Thematic analysis and code development","author":"Boyatzis","year":"1998"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1177\/1049732307307031","article-title":"Choose your method: a comparison of phenomenology, discourse analysis, and grounded theory","volume":"17","author":"Starks","year":"2007","journal-title":"Qual Health Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s40259-018-0281-6","article-title":"Knowledge of adverse drug reaction reporting and the pharmacovigilance of biological medicines: a survey of healthcare professionals in Ireland","volume":"32","author":"O\u2019Callaghan","year":"2018","journal-title":"BioDrugs"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1371\/journal.pone.0152221","article-title":"Health professionals' knowledge, attitudes and practices about pharmacovigilance in India: a systematic review and metaanalysis","volume":"11","author":"Bhagavathula","year":"2016","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jsps.2018.04.012","article-title":"Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-center cross-sectional study","volume":"26","author":"AlShammari","year":"2018","journal-title":"Saudi Pharm J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/inthealth\/ihy073","article-title":"Knowledge, attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital","volume":"11","author":"Erg\u00fcn","year":"2019","journal-title":"Int Health"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1658-631X.170881","article-title":"Pharmaceutical care in the community pharmacies of Saudi Arabia: present status and possibilities for improvement. Saudi J med","volume":"4","author":"Alanazi","year":"2016","journal-title":"Med Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1186\/s12913-022-08395-3","article-title":"Perceptions, practices, and barriers to reporting of adverse drug reactions among HIV-infected patients and their doctors in 3 public sector hospitals of the Ethekwini metropolitan, Kwa-Zulu Natal: a cross-sectional and retrospective analysis","volume":"22","author":"Zondi","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/pds.2630030205","article-title":"Reporting of adverse drug reactions in relation to general medical admissions to a teaching hospital in Hong Kong","volume":"3","author":"Chan","year":"1994","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/pds.702","article-title":"Contribution of pharmacists to the reporting of adverse drug reactions","volume":"11","author":"Van Grootheest","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2125.2001.01306.x","article-title":"Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting","volume":"51","author":"Green","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"00469580241246464","DOI":"10.1177\/00469580241246464","article-title":"Pharmacovigilance concept knowledge, perspectives and attitudes: a cross-sectional study among community pharmacists","volume":"61","author":"Abu Assab","year":"2024","journal-title":"Inquiry"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11096-008-9209-4","article-title":"The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul","volume":"30","author":"Toklu","year":"2008","journal-title":"Pharm World Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40290-019-00267-2","article-title":"A retrospective review of serious adverse drug reaction reports in the Nigerian VigiFlow database from September 2004 to December 2016","volume":"33","author":"Ogar","year":"2019","journal-title":"Pharm Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/1995-7645.338436","article-title":"Patterns of adverse drug reaction reporting in Ethiopia: a database analysis of spontaneous reports from 2013 to 2018","volume":"15","author":"Anebo","year":"2022","journal-title":"Asian Pac J Trop Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jgs.15195","article-title":"Meta-analysis of interventions to reduce adverse drug reactions in older adults","volume":"66","author":"Gray","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0253588","DOI":"10.1371\/journal.pone.0253588","article-title":"Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: a systematic review and metaanalysis","volume":"16","author":"Jaam","year":"2021","journal-title":"PLoS One"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1513611\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:59:07Z","timestamp":1736146747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1513611\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":44,"alternative-id":["10.3389\/fmed.2024.1513611"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1513611","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1513611"}}